Shaji Kumar, MD
Shaji Kumar, MD is a consultant in the Division of Hematology at Mayo Clinic, and Professor of Medicine in the College of Medicine, Mayo Clinic, Rochester, MN. He is currently the Medical Director for the Cancer Center Clinical Trials Office. He also serves as the co-chair of the NCI Myeloma Steering Committee.
Dr. Kumar’s research efforts are directed toward studying novel treatment approaches in myeloma through well-designed clinical trials. Currently he is principal investigator on multiple phase I, II, and III trials for plasma cell malignancies, His laboratory efforts are focused on development of new agents for plasma cell malignancies, with a particular focus on the tumor microenvironment and its interaction with the tumor cells and understanding the risk of progression of monoclonal gammopathies including MGUS and smoldering myeloma.